GlassScriptPhysician profile
Jeremiah Depta
NPI 1548453939
$723,499.47
in general payments reported to CMS, 2019-2025
18 companies · $111K in 2025
The $111K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65K · 2020: $59K · 2021: $75K · 2022: $110K · 2023: $164K · 2024: $139K · 2025: $111K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $317K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $49K · Travel and Lodging: $35K · Food and Beverage: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $316,712.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $49,128.79 |
| Travel and Lodging | $35,431.54 |
| Food and Beverage | $13,042.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $607,981.36 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Boston Scientific Corporation | $101,366.73 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Medtronic, INC. | $8,182.56 | 2021-2025 | Symplicity G3, Linq II |
| Abbott Laboratories | $5,063.93 | 2019-2025 | Triclip, Mitraclip, Perclose Prostyle |
| W. L. Gore & Associates, INC. | $227.31 | 2021-2024 | Gore Cardioform Septal Occluder |
| Shockwave Medical, INC | $186.25 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Asahi Intecc USA, INC. | $122.16 | 2021 | |
| Pfizer INC. | $75.17 | 2019-2025 | |
| Smith+Nephew, INC. | $58.66 | 2024-2025 | Pico |
| Biosense Webster, INC. | $55.65 | 2023-2025 | Nuvision Ice Catheter, Na, Soundstar |
| Preventice Services, LLC | $35.12 | 2021 | |
| Irhythm Technologies, INC. | $34.50 | 2023 | Zio Xt Patch |
| Cardiva Medical, INC. | $29.15 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Astrazeneca Pharmaceuticals LP | $27.81 | 2021 | |
| Cvrx, INC. | $24.48 | 2023 | Barostim Neo System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $15.92 | 2023 | Arcalyst |
| Ge Healthcare | $12.71 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremiah Depta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.